Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic Treatment

NCT06592612 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma
Oligoprogression

Interventions

RADIATION: SBRT and second-line systemic therapy
DRUG: Second-line systemic therapy

Sponsor

Sun Yat-sen University